Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6400
-0.0280 (-4.19%)
May 14, 2025, 1:11 PM - Market open
Adicet Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 28.13 | 56.5 | 159.71 | 257.66 | 277.54 | 84.33 | Upgrade
|
| Short-Term Investments | 122.31 | 119.81 | - | - | - | 10.28 | Upgrade
|
| Cash & Short-Term Investments | 150.44 | 176.3 | 159.71 | 257.66 | 277.54 | 94.61 | Upgrade
|
| Cash Growth | -39.24% | 10.39% | -38.01% | -7.17% | 193.34% | 51.63% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.19 | - | Upgrade
|
| Other Receivables | - | - | - | 0.44 | 0.03 | 2.73 | Upgrade
|
| Receivables | - | - | - | 0.44 | 0.21 | 2.73 | Upgrade
|
| Prepaid Expenses | 3.12 | 3.83 | 2.56 | 2.95 | 4.68 | 2.76 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.23 | Upgrade
|
| Total Current Assets | 153.56 | 180.14 | 162.27 | 261.04 | 282.44 | 100.34 | Upgrade
|
| Property, Plant & Equipment | 34.49 | 36.75 | 44.2 | 48.98 | 35 | 25.86 | Upgrade
|
| Goodwill | - | - | - | 19.46 | 19.46 | 20.09 | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 1.19 | Upgrade
|
| Other Long-Term Assets | 3.22 | 3.33 | 0.82 | 1.21 | 2.04 | 6.36 | Upgrade
|
| Total Assets | 191.27 | 220.22 | 207.3 | 330.69 | 338.94 | 153.84 | Upgrade
|
| Accounts Payable | 4.4 | 4.83 | 2.63 | 4.4 | 3.26 | 1.55 | Upgrade
|
| Accrued Expenses | 9.06 | 11.43 | 13.44 | 12.81 | 6.68 | 5.73 | Upgrade
|
| Current Portion of Leases | 2.98 | 3.13 | 3.22 | 2.49 | 1.57 | 1.22 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 4.81 | 13.98 | Upgrade
|
| Total Current Liabilities | 16.45 | 19.39 | 19.29 | 19.71 | 16.32 | 22.48 | Upgrade
|
| Long-Term Leases | 13.26 | 14.1 | 17.7 | 18.53 | 19.38 | 20.42 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.13 | Upgrade
|
| Other Long-Term Liabilities | 0.12 | 0.12 | 0.13 | 0.11 | 0.12 | 0.98 | Upgrade
|
| Total Liabilities | 29.83 | 33.61 | 37.12 | 38.35 | 35.81 | 44.01 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 687.56 | 684.48 | 550.94 | 530.45 | 471.45 | 216.13 | Upgrade
|
| Retained Earnings | -526.11 | -497.89 | -380.77 | -238.11 | -168.32 | -106.33 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0.02 | - | - | - | 0.02 | Upgrade
|
| Total Common Equity | 161.45 | 186.61 | 170.18 | 292.34 | 303.13 | 109.83 | Upgrade
|
| Shareholders' Equity | 161.45 | 186.61 | 170.18 | 292.34 | 303.13 | 109.83 | Upgrade
|
| Total Liabilities & Equity | 191.27 | 220.22 | 207.3 | 330.69 | 338.94 | 153.84 | Upgrade
|
| Total Debt | 16.25 | 17.23 | 20.92 | 21.02 | 20.94 | 21.64 | Upgrade
|
| Net Cash (Debt) | 134.19 | 159.07 | 138.79 | 236.63 | 256.6 | 72.98 | Upgrade
|
| Net Cash Growth | -41.03% | 14.61% | -41.35% | -7.78% | 251.63% | -0.02% | Upgrade
|
| Net Cash Per Share | 1.48 | 1.81 | 3.22 | 5.76 | 8.29 | 9.97 | Upgrade
|
| Filing Date Shares Outstanding | 82.71 | 82.69 | 82.15 | 42.95 | 39.88 | 31.78 | Upgrade
|
| Total Common Shares Outstanding | 82.71 | 82.57 | 43.27 | 42.95 | 39.74 | 19.68 | Upgrade
|
| Working Capital | 137.12 | 160.74 | 142.99 | 241.33 | 266.12 | 77.86 | Upgrade
|
| Book Value Per Share | 1.95 | 2.26 | 3.93 | 6.81 | 7.63 | 5.58 | Upgrade
|
| Tangible Book Value | 161.45 | 186.61 | 170.18 | 272.88 | 283.67 | 88.55 | Upgrade
|
| Tangible Book Value Per Share | 1.95 | 2.26 | 3.93 | 6.35 | 7.14 | 4.50 | Upgrade
|
| Machinery | - | 15 | 14.31 | 7.86 | 6.02 | 4.97 | Upgrade
|
| Construction In Progress | - | 0.2 | 0.27 | 9.29 | 13.01 | 1.09 | Upgrade
|
| Leasehold Improvements | - | 28.23 | 26.64 | 19.96 | 1.61 | 1.43 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.